Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of peginterferon lambda-1a-treated subjects with chronic hepatitis C
2011-005293-31Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon lambda-1a in hepatitis C virus infection, sponsored by Bristol Myers Squibb. Started Feb 2012; status: completed.
02
Drugs
peginterferon lambda-1a
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2011-005293-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005293-31.